Ian Estepan

Insider Reports History

Entity
Individual
Location
215 First Street, Ste 415, Cambridge, MA
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Ian Estepan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Estepan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sarepta Therapeutics, Inc. Chief Financial Officer Common Stock 33.9K $4.66M $137.36 Aug 30, 2024 Direct
Sarepta Therapeutics, Inc. Chief Financial Officer Performance Stock Units 0 $0 $163.23 Jun 21, 2024 Direct
Sarepta Therapeutics, Inc. Chief Financial Officer Stock Option (right to buy) 12.5K Mar 1, 2024 Direct

Insider Reports Filed by Ian Estepan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRPT Sarepta Therapeutics, Inc. Aug 30, 2024 1 -$822K 4 Sep 3, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Jun 21, 2024 5 -$409K 4 Jun 25, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 7, 2024 2 -$191K 4 Mar 11, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2024 1 -$174K 4 Mar 6, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2024 4 -$200K 4 Mar 5, 2024 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 8, 2023 1 -$114K 4 Mar 10, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 6, 2023 3 -$215K 4 Mar 8, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2023 1 -$55.8K 4 Mar 3, 2023 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 4, 2022 4 -$135K 4 Mar 8, 2022 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Mar 1, 2022 1 -$28.2K 4 Mar 1, 2022 Chief Financial Officer
SRPT Sarepta Therapeutics, Inc. Sep 8, 2021 1 -$127K 4 Sep 9, 2021 Chief Financial Officer